|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 26, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00707.2002
Submitted on August 13, 2002
Accepted on September 20, 2002
1 Mircorarray Center, NIEHS, NIH, RTP, NC, USA
2 Laboratory of Signal Transduction, NIEHS, NIH, RTP, NC, USA
* To whom correspondence should be addressed. E-mail: murphy1{at}niehs.nih.gov.
Dilated cardiomyopathy, a disease of unknown etiology and pathogenesis is associated with heart failure and compensatory hypertrophy. Although cell and animal models suggest a role for altered gene expression in the transition to heart failure, there is a paucity of data derived from study of human heart tissue. In this study, we used DNA microarray profiling to investigate changes in expression of genes involved in apoptosis that occur in human idiopathic dilated cardiomyopathic hearts that had progressed to heart failure. We observed altered gene expression consistent with a pro-apoptotic shift in the TNF-
signaling pathway. Specifically we found decreased expression of the TNF-
and NF-
B induced anti-apoptotic genes such as GADD45ß, Flice inhibitory protein (FLIP) and TNF induced protein 3 (A20). Consistent with a role for apoptosis in heart failure, we also observed a significant decrease in phosphorylation of BAD at serine 112. This study identifies several pathways that are altered in human heart failure and provides new targets for therapy.
This article has been cited by other articles:
![]() |
G. Kewalramani, P. Puthanveetil, F. Wang, M. S. Kim, S. Deppe, A. Abrahani, D. S. Luciani, J. D. Johnson, and B. Rodrigues AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death Cardiovasc Res, October 1, 2009; 84(1): 42 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ruppert, T. Meyer, S. Pankuweit, E. Moller, R. C. Funck, W. Grimm, B. Maisch, and German Heart Failure Network Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 360 - 369.e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aharinejad, O. Andrukhova, T. Lucas, A. Zuckermann, G. Wieselthaler, E. Wolner, and M. Grimm Programmed Cell Death in Idiopathic Dilated Cardiomyopathy is Mediated by Suppression of the Apoptosis Inhibitor Apollon Ann. Thorac. Surg., July 1, 2008; 86(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ashrafian and H. Watkins Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gustafsson and R. A. Gottlieb Bcl-2 family members and apoptosis, taken to heart Am J Physiol Cell Physiol, January 1, 2007; 292(1): C45 - C51. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schiekofer, I. Shiojima, K. Sato, G. Galasso, Y. Oshima, and K. Walsh Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure Physiol Genomics, October 11, 2006; 27(2): 156 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Schwinn and M. Podgoreanu Editorial I: The new age of medical genomics Br. J. Anaesth., August 1, 2005; 95(2): 119 - 121. [Full Text] [PDF] |
||||
![]() |
J. Rysa, H. Leskinen, M. Ilves, and H. Ruskoaho Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure Hypertension, May 1, 2005; 45(5): 927 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Napoli, L O Lerman, V Sica, A Lerman, G Tajana, and F de Nigris Microarray analysis: a novel research tool for cardiovascular scientists and physicians Heart, June 1, 2003; 89(6): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |